DF
AZN icon

Dunhill Financial’s AstraZeneca AZN Stock Holding History

Dunhill Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
214
+206
+2,575% +$38.7K 0.01% 363
2026
Q1 		$1.58K Sell
8
-35
-81% -$6.75K ﹤0.01% 858
2025
Q4 		$7.91K Buy
43
+1
+2% +$175 ﹤0.01% 536
2025
Q3 		$6.37K Buy
42
+6
+17% +$908 ﹤0.01% 535
2025
Q2 		$4.97K Buy
36
+4
+13% +$561 ﹤0.01% 547
2025
Q1 		$4.7K Sell
32
-32
-50% -$4.63K ﹤0.01% 580
2024
Q4 		$8.39K Buy
64
+32
+100% +$4.48K ﹤0.01% 428
2024
Q3 		$4.99K Hold
32
– – ﹤0.01% 553
2024
Q2 		$4.99K Hold
32
– – ﹤0.01% 394
2024
Q1 		$4.34K Hold
32
– – ﹤0.01% 344
2023
Q4 		$3.9K Buy
+32
New +$4.16K ﹤0.01% 321

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dunhill Financial's AZN Position: Q2 2026 in Review

Dunhill Financial increased its AstraZeneca (AZN) stake by 2,575% in Q2 2026, buying an estimated $38.7K and bringing the position to 214 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #363.

Dunhill Financial first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Dunhill Financial held 214 shares of AstraZeneca worth $40K as of Q2 2026.
  • Dunhill Financial bought 206 AstraZeneca shares in Q2 2026, an estimated $38.7K.
  • AstraZeneca made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #363 holding.
  • Dunhill Financial first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.